Similarly, in a mouse model of psoriasis using imiquimod (IMQ), depression-like symptoms were observed alongside IL-17A induction, and treatment with an anti-IL-17A antibody led to a reduction in IMQ-induced depression-like behaviors (Nadeem et al. 2017). Here, IL17A is linked to major depressive disorder.